Director Keith Humphreys purchased Indivior Pharmaceuticals ($INDV) shares once on the open market in the last year, for a total of $27,429. His most recent buy was on January 5, 2026. This places him 3,518th out of nearly 5,000 insiders by purchase value, well below the average of 1.5 million dollars across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Humphreys Keith | Director | A | Common Stock | 3722 | $0.00 | 9,524.0000 | 125,000,000 | 64.15% | 0.00% |
| Jan. 5, 2026 | Indivior Pharmaceuticals, Inc. | $INDV | Humphreys Keith | Director | P | Ordinary Shares | 775 | $35.39 | 5,802.0000 | 125,000,000 | 15.42% | 0.00% |